This invention relates to multicyclic compounds, pharmaceutical compositions comprising them, and methods of their use in, for example, the treatment of cognitive disorders.
PYRROLIDINE OXADIAZOLE- AND THIADIAZOLE OXIME DERIVATIVES BEING OXYTOCIN RECEPTOR ANTAGONISTS.
申请人:Applied Research Systems ARS Holding N.V.
公开号:EP1444225A2
公开(公告)日:2004-08-11
US8772291B2
申请人:——
公开号:US8772291B2
公开(公告)日:2014-07-08
[EN] PYRROLIDINE OXADIAZOLE- AND THIADIAZOLE DERIVATIVES<br/>[FR] DERIVES DE PYRROLIDINE OXADIAZOLES ET THIADIAZOLES
申请人:APPLIED RESEARCH SYSTEMS
公开号:WO2002102799A2
公开(公告)日:2002-12-27
The present invention is related to pyrrolidine oxadiazole and thiadiazole derivatives for use as pharmaceutically active compounds, as well as pharmaceutical formulations containing such pyrrolidine oxadiazole derivatives. Said pyrrolidine derivatives are useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea. In particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor. More preferably, said compounds are useful in the treatment and/or prevention of disease states mediated by oxytocin, including preterm labor, premature birth and dysmenorrhea. The present invention is furthermore related to novel pyrrolidine derivatives as well as to methods of their preparation. (I) B is a oxadiazole or thiadiazole group.